[Glucocorticoid-induced osteoporosis and bone mineral densimetry].
While the diagnosis and management of primary osteoporosis have been established and widely utilized, these for glucocorticoid-induced osteoporosis (GIOP), i.e. a representative of secondary osteoporosis, are on their way. GIOP caused fractures at a higher bone mineral density (BMD) compared to primary osteoporosis. The cut off value of the BMD for prediction of fractures was around 80% of the young adult means (T-score; -1.5). As this value would give a useful diagnostic point for initiating treatments, measurements of BMD should be a significant tool for management of GIOP.
Tanaka
Ikuko
I
Department of Laboratory Medicine, Fujita Health University School of Medicine.
Oshima
Hisaji
H
D015502:Absorptiometry, Photon; D000328:Adult; D015519:Bone Density; D001842:Bone and Bones / Q000000981:diagnostic imaging / Q000503:physiopathology; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011239:Prednisolone / Q000009:adverse effects*; D012372:ROC Curve; D016032:Randomized Controlled Trials as Topic
D004164:Diphosphonates; D005938:Glucocorticoids; D011239:Prednisolone